BioSpace News Archive

The Company expects to use the net proceeds of the offering to fund its development of inclisiran and for general corporate purposes.

Amring Pharmaceuticals Inc., a generic pharmaceutical and ophthalmic medical device company, announced that it has launched two valued drugs into its generic portfolio and to the U.S. Market

Thought leaders from Arizona-based Maricopa Integrated Health System and nThrive will share how a holistic approach to denials management can help providers thrive in the new clinically-driven revenue cycle management environment

Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (“Tiziana” or the “Company”), a biotechnology company focusing on the discovery and development of innovative therapeutics for inflammation and oncology indications, notes the advance publication of a scientific article by third party researchers in the peer reviewed journal Crohn’s & Colitis 360

It is a common understanding in scientific research that the male species, in general, are frailer and experience higher rates of mortality across their lifespans than females.

CPhI China event surges 25% as Asian CPhI editions report robust growth

Cardioxane is used as a cardio protectant with cancer chemotherapy treatment.

This year, the meeting is being held in Basel, Switzerland from June 22nd to June 26th.

Despite our advances in health care over the last century, millions now face new risks, including unaffordable costs and unsuitable health infrastructure

The US National Cancer Institute has awarded Bound Therapeutics LLC a Small Business Technology Transfer grant starting 15 June for $300,000 to develop “microRNA-21 Blockade of Triple Negative Breast Cancer”.